STAT+: Drug makers urge Biden to reject proposal to waive patent rights on Covid-19 products

More than two dozen of the largest pharmaceutical companies are urging President Biden to reject a proposal before the World Trade Organization to temporarily waive patent rights in order to widen access to Covid-19 medical products to mostly low-income countries.

In a March 5 letter, the drug makers argue that, contrary to assertions, intellectual property is not a barrier to ensuring that vaccines and therapies become available on a global basis. Along with their trade groups, the companies also maintained that eliminating intellectual property protection to allow other manufacturers to make certain products would not speed production or access.

Continue to STAT+ to read the full story…

STAT+: Drug makers urge Biden to reject proposal to waive patent rights on Covid-19 products

Leave a Reply

Your email address will not be published. Required fields are marked *

Scroll to top